Abstract
This study was designed to investigate the possible antiplatelet effect of aqueous whole-plant C. aronia syn: Azarolus (L) extract using Wistar albino rats as a model.
Forty-two male albino Wistar rats weighing 200 to 250g were divided into seven groups with six rats in each group. Group 1 served as the control and received equal volumes of distilled water. Groups 2–6 served as the experimental groups and were given C. aronia extract at doses of 100, 200, 500, 1,000, and 2,000mg/kg, while group 7 served as a positive control and was given aspirin (25mg/kg). All the doses were administered orally once a day and the treatment was continued for seven days. In all groups, at the end of the experimental procedure, blood samples were obtained for platelet function measurements, including PFA-100, thromboxane B2 levels, platelet count, and haematocrit. The bleeding time was determined using a modified tail cutting method described previously.
The aqueous C. aronia syn. Azarolus (L) extract significantly altered the bleeding time and the closure time, as determined by the PFA-100 and thromboxane B2 levels, suggesting significant platelet function inhibition. These effects were observed with C. aronia doses between 100 – 500mg/kg, which yielded thromboxane B2 levels of 1,000mg/kg, whereas the higher dose (2,000mg/kg) produced opposite effects on these parameters.
C. aronia syn. Azarolus (L) aqueous extract has antiplatelet effects in Wistar albino rats.